Blister clinical trials
The registry lists 36 studies for Blister across more than 10 countries. 3 are recruiting or about to start. 15 of them are mainly about Blister (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05.
Get an email when these change. Save the Blister studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Stanford University (3) · Institut de Formation et de Recherche en Médecine de Montagne (2) · Janssen Research & Development, LLC (1) · Capital Medical University (1) · All India Institute of Medical Sciences, Bhubaneswar (1) · SK Life Science, Inc. (1) · AstraZeneca (1) · Chelsea and Westminster NHS Foundation Trust (1)
What is being tested here
Drugs under test in Blister studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- May 2027NanoSALV vs Standard Topical Care Pathway in Sports-Related Skin Lesions · Phase 3 · Shahab Alizadeh
Who these studies take
No Blister study is recruiting now.
Across all 36 studies, recruiting or not: 39% stop at 75 or younger and 33% at 65; 25% take children; 0% are for women only and 6% for men only; 44% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 36 of 36. search them.
- NanoSALV vs Standard Topical Care Pathway in Sports-Related Skin LesionsNot yet recruitingNCT07807904Phase 3
- Opioid Package Prototype (OPP)Not yet recruitingNCT04598074Not applicable1 country
- Polypropylene vs Polyglactin in Suturing of the LungNot yet recruitingNCT06115447
- The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic DiseasesCompletedNCT000015051 country
- Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa SimplexCompletedNCT03453632Phase 2/31 country
- Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous PemphigoidCompletedNCT02226146Phase 22 countries
- Efficacy and Safety of add-on Dapsone Versus add-on Methotrexate in Patients With Bullous PemphigoidCompletedNCT05984381Phase 41 country
- An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated SkinCompletedNCT009231041 country
- Thoracoscopy for Idiopathic Pneumothorax in ChildrenCompletedNCT067344421 country
- A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.TerminatedNCT04612790Phase 311 countries
- Visual Distraction as a Means of Enhancing Child ResistanceCompletedNCT01859780Not applicable1 country
- Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa.CompletedNCT05378997Phase 11 country
- Spectroscopic Profiling of Extracellular Vesicles By Resonant Gold Nanostructures in the InfraredStatus unknownNCT062661951 country
- Kinetics of cEVs Over the 24-hour Dosing Interval After Low-dose Aspirin AdministrationCompletedNCT05584943
- Pro-Resolving Mediators in Acute Inflammation in HumansCompletedNCT04308889Early Phase 11 country
- Evaluation of the Effectiveness of the Local Application of Lemon in the Prevention of Blisters in Ultra-trail RunnersStatus unknownNCT05086640Not applicable1 country
- Epidemiological Characteristics and Prevention Methods of Blisters in Ultra-trail RunnersStatus unknownNCT050716511 country
- Blister Eradication Looking at Impact of Experimental Versus Established RegimensStatus unknownNCT03835806Not applicable3 countries
- Human Immunity Against Staphylococcus Aureus Skin InfectionCompletedNCT02262819Phase 11 country
- Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy SubjectsCompletedNCT03306589Phase 11 country
- Prevention Trial Assessing Paper-Tape in Endurance Distances (PreTAPED)CompletedNCT01120808Phase 11 country
- Prevention Trial Assessing Paper-Tape in Endurance Distances II (Pre-TAPED II)CompletedNCT01945112Not applicable1 country
- An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN).CompletedNCT00492323Phase 2
- Proof of Concept Study for a Dressing GloveCompletedNCT032416281 country
- Study of Megakaryocytes From Patients With Abnormal Platelet VesiclesCompletedNCT000864761 country
- Evaluation and Comparison of Keloids and Second Degree Burns Blisters FluidStatus unknownNCT016277691 country
- Assessing Foot Injuries in Infantry Recruits Wearing Different BootsCompletedNCT02810002Phase 1/2
- A Study to Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy ParticipantsCompletedNCT02343783Early Phase 12 countries
- A Study Of The Safety, Tolerability, And Pharmacokinetics Of Multiple Doses Of PF-05180999 In Healthy AdultsWithdrawnNCT01981486Phase 1
- Bronchoscopic Intrabullous Autologous Blood Instillation (BIABI) for EmphysemaStatus unknownNCT01727037Phase 21 country
- Evaluation of Three Types of Dressings After Hip SurgeryCompletedNCT01469871Phase 41 country
- Hydrogel Blister Patch Prototype Treatment for Foot Blisters on the HeelCompletedNCT01088685Not applicable1 country
- Pathogenesis of Primary Spontaneous PneumothoraxStatus unknownNCT011350041 country
- Subconjunctival Bevacizumab Effect on Bleb VascularityStatus unknownNCT00854529Phase 21 country
- Bleb Vascularity Change After Subconjunctival Injection BevacizumabStatus unknownNCT00815594Phase 41 country
- Comparison of Subconjunctival 5-Fluorouracil (FU) Injection and Mitomycin C for Treatment of Early Bleb FailureStatus unknownNCT00644215Not applicable1 country